Abstract
Radiomics (or texture analysis) is a new imaging analysis technique that allows calculating the distribution of texture features of pixel and voxel values depend on the type of ROI (3D or 2D), their relationships in the image. Depending on the software, up to several thousand texture elements can be obtained. Radiomics opens up wide opportunities for differential diagnosis and prognosis of pancreatic neoplasias. The aim of this review was to highlight the main diagnostic advantages of texture analysis in different pancreatic tumors. The review describes the diagnostic performance of radiomics in different pancreatic tumor types, application methods, and problems. Texture analysis in PDAC is able to predict tumor grade and associates with lymphovascular invasion and postoperative margin status. In pancreatic neuroendocrine tumors, texture features strongly correlate with differentiation grade and allows distinguishing it from the intrapancreatic accessory spleen. In pancreatic cystic lesions, radiomics is able to accurately differentiate MCN from SCN and distinguish clinically insignificant lesions from IPMNs with advanced neoplasia. In conclusion, the use of the CT radiomics approach provides a higher diagnostic performance of CT imaging in pancreatic tumors differentiation and prognosis. Future studies should be carried out to improve accuracy and facilitate radiomics workflow in pancreatic imaging.
Similar content being viewed by others
References
McGuigan A, Kelly P, Turkington RC et al (2018) Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol 24:4846–4861
Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30. https://doi.org/10.3322/caac.21442
Shah MH, Goldner WS, Halfdanarson TR et al (2018) Neuroendocrine and adrenal tumors, version 2.2018 featured updates to the nccn guidelines. JNCCN J Natl Compr Cancer Netw 16:693–702
Daly MB, Pilarski R, Yurgelun MB et al (2020) Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020 featured updates to the NCCN guidelines. JNCCN J Natl Compr Cancer Netw 18:380–391. https://doi.org/10.6004/jnccn.2020.0017
Khanna L, Prasad SR, Sunnapwar A et al (2020) Pancreatic neuroendocrine neo-plasms: 2020 update on pathologic and imaging findings and classification. Radiographics 40:1240–1262. https://doi.org/10.1148/rg.2020200025
Xuan W, You G (2020) Detection and diagnosis of pancreatic tumor using deep learning-based hierarchical convolutional neural network on the internet of medical things platform. Futur Gener Comput Syst 111:132–142. https://doi.org/10.1016/j.future.2020.04.037
Elbanna KY, Jang H-J, Kim TK (2020) Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review. Insights Imaging 11:58. https://doi.org/10.1186/s13244-020-00861-y
Nioche C, Orlhac F, Boughdad S et al (2018) Lifex: A freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res 78:4786–4789. https://doi.org/10.1158/0008-5472.CAN-18-0125
Inzani F, Petrone G, Rindi G (2018) The new world health organization classification for pancreatic neuroendocrine Neoplasia. Endocrinol Metab Clin North Am 47:463–470. https://doi.org/10.1016/j.ecl.2018.04.008
Tanaka H, Hijioka S, Hosoda W et al (2020) Pancreatic neuroendocrine carcinoma G3 may be heterogeneous and could be classified into two distinct groups. Pancreatology 20:1421–1427. https://doi.org/10.1016/j.pan.2020.07.400
Liang W, Yang P, Huang R et al (2019) A combined nomogram model to preoperatively predict histologic grade in pancreatic neuroendocrine tumors. Clin Cancer Res 25:584–594. https://doi.org/10.1158/1078-0432.CCR-18-1305
Guo C, Zhuge X, Wang Z et al (2019) Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade. Abdom Radiol 44:576–585. https://doi.org/10.1007/s00261-018-1763-1
Canellas R, Burk KS, Parakh A, Sahani DV (2018) Prediction of Pancreatic neuroendocrine tumor grade based on CT features and texture analysis. Am J Roentgenol 210:341–346. https://doi.org/10.2214/AJR.17.18417
D’Onofrio M, Ciaravino V, Cardobi N et al (2019) CT enhancement and 3D texture analysis of pancreatic neuroendocrine Neoplasms. Sci Rep. https://doi.org/10.1038/s41598-018-38459-6
Bian Y, Jiang H, Ma C et al (2020) CT-based radiomics score for distinguishing between grade 1 and grade 2 nonfunctioning pancreatic neuroendocrine tumors. Am J Roentgenol 215:852–863. https://doi.org/10.2214/AJR.19.22123
Gu D, Hu Y, Ding H et al (2019) CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study. Eur Radiol 29:6880–6890. https://doi.org/10.1007/s00330-019-06176-x
Choi TW, Kim JH, Yu MH et al (2018) Pancreatic neuroendocrine tumor: prediction of the tumor grade using CT findings and computerized texture analysis. Acta Radiol 59:383–392. https://doi.org/10.1177/0284185117725367
Azoulay A, Cros J, Vullierme MP et al (2020) Morphological imaging and CT histogram analysis to differentiate pancreatic neuroendocrine tumor grade 3 from neuroendocrine carcinoma. Diagn Interv Imaging 101:821–830. https://doi.org/10.1016/j.diii.2020.06.006
Ohki K, Igarashi T, Ashida H et al (2021) Usefulness of texture analysis for grading pancreatic neuroendocrine tumors on contrast-enhanced computed tomography and apparent diffusion coefficient maps. Jpn J Radiol 39:66–75. https://doi.org/10.1007/s11604-020-01038-9
Bian Y, Zhao Z, Jiang H et al (2020) <scp>Noncontrast</scp> Radiomics approach for predicting grades of nonfunctional pancreatic neuroendocrine tumors. J Magn Reson Imag 52:1124–1136. https://doi.org/10.1002/jmri.27176
Pavic M, Bogowicz M, Würms X et al (2018) Influence of inter-observer delineation variability on radiomics stability in different tumor sites. Acta Oncol (Madr) 57:1070–1074. https://doi.org/10.1080/0284186X.2018.1445283
Loi S, Mori M, Benedetti G et al (2020) Robustness of CT radiomic features against image discretization and interpolation in characterizing pancreatic neuroendocrine neoplasms. Phys Medica 76:125–133. https://doi.org/10.1016/j.ejmp.2020.06.025
Gruzdev IS, Zamyatina KA, Tikhonova VS et al (2020) Reproducibility of CT texture features of pancreatic neuroendocrine neoplasms. Eur J Radiol. https://doi.org/10.1016/j.ejrad.2020.109371
Benedetti G, Mori M, Panzeri MM et al (2021) CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors. Radiol Medica. https://doi.org/10.1007/s11547-021-01333-z
Belousova E, Karmazanovsky G, Kriger A et al (2017) Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades. Clin Radiol 72:150–158. https://doi.org/10.1016/j.crad.2016.10.021
Lin X, Xu L, Wu A et al (2019) Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography. Acta Radiol 60:553–560. https://doi.org/10.1177/0284185118788895
van der Pol CB, Lee S, Tsai S et al (2019) Differentiation of pancreatic neuroendocrine tumors from pancreas renal cell carcinoma metastases on CT using qualitative and quantitative features. Abdom Radiol 44:992–999. https://doi.org/10.1007/s00261-018-01889-x
Li J, Lu J, Liang P et al (2018) Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: using whole-tumor CT texture analysis as quantitative biomarkers. Cancer Med 7:4924–4931. https://doi.org/10.1002/cam4.1746
Karmazanovsky G, Belousova E, Schima W et al (2019) Nonhypervascular pancreatic neuroendocrine tumors: spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma. Eur J Radiol 110:66–73. https://doi.org/10.1016/j.ejrad.2018.04.006
Ren S, Chen X, Wang Z et al (2019) Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography. PLoS ONE. https://doi.org/10.1371/journal.pone.0211566
Reinert CP, Baumgartner K, Hepp T et al (2020) Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase. Abdom Radiol 45:750–758. https://doi.org/10.1007/s00261-020-02406-9
Yu H, Huang Z, Li M et al (2020) Differential Diagnosis of Nonhypervascular pancreatic neuroendocrine neoplasms from pancreatic ductal adenocarcinomas, based on computed tomography radiological features and texture analysis. Acad Radiol 27:332–341. https://doi.org/10.1016/j.acra.2019.06.012
Sahani DV, Sainani NI, Blake MA et al (2011) Prospective evaluation of reader performance on MDCT in characterization of cystic pancreatic lesions and prediction of cyst biologic aggressiveness. Am J Roentgenol 197:W53–W61. https://doi.org/10.2214/AJR.10.5866
Dalal V, Carmicheal J, Dhaliwal A et al (2020) Radiomics in stratification of pancreatic cystic lesions: machine learning in action. Cancer Lett 469:228–237
Dmitriev K, Kaufman AE, Javed AA et al (2017) Classification of pancreatic cysts in computed tomography images using a random forest and convolutional neural network ensemble. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). Springer, New York, pp 150–158
Wei R, Lin K, Yan W et al (2019) Computer-aided diagnosis of pancreas serous cystic neoplasms: a radiomics method on preoperative MDCT images. Technol Cancer Res Treat. https://doi.org/10.1177/1533033818824339
Yang J, Guo X, Ou X et al (2019) Discrimination of pancreatic serous cystadenomas from mucinous cystadenomas with CT textural features: based on machine learning. Front Oncol 9:494. https://doi.org/10.3389/fonc.2019.00494
Ha S, Choi H, Cheon GJ et al (2014) Autoclustering of non-small cell lung carcinoma subtypes on 18F-FDG PET using texture analysis: a preliminary result. Nucl Med Mol Imag 48:278–286. https://doi.org/10.1007/s13139-014-0283-3
Permuth JB, Choi J, Balarunathan Y et al (2016) Combining radiomic features with a miRNA classifier may improve prediction of malignant pathology for pancreatic intraductal papillary mucinous neoplasms. Oncotarget 7:85785–85797. https://doi.org/10.18632/oncotarget.11768
Chakraborty J, Midya A, Gazit L et al (2018) CT radiomics to predict high-risk intraductal papillary mucinous neoplasms of the pancreas. Med Phys 45:5019–5029. https://doi.org/10.1002/mp.13159
Cassinotto C, Chong J, Zogopoulos G et al (2017) Resectable pancreatic adenocarcinoma: role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes. Eur J Radiol 90:152–158. https://doi.org/10.1016/j.ejrad.2017.02.033
Yun G, Kim YH, Lee YJ et al (2018) Tumor heterogeneity of pancreas head cancer assessed by CT texture analysis: association with survival outcomes after curative resection. Sci Rep. https://doi.org/10.1038/s41598-018-25627-x
Cozzi L, Comito T, Fogliata A et al (2019) Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma. PLoS ONE 14:e0210758. https://doi.org/10.1371/journal.pone.0210758
Chen X, Oshima K, Schott D et al (2017) Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: an exploratory study. PLoS ONE. https://doi.org/10.1371/journal.pone.0178961
Zhang W, Cai W, He B et al (2018) A radiomics-based formula for the preoperative prediction of postoperative pancreatic fistula in patients with pancreaticoduodenectomy. Cancer Manag Res 10:6469–6478. https://doi.org/10.2147/CMAR.S185865
Park S, Chu LC, Hruban RH et al (2020) Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features. Diagn Interv Imaging 101:555–564. https://doi.org/10.1016/j.diii.2020.03.002
Zaheer A, Singh VK, Akshintala VS et al (2014) Differentiating autoimmune pancreatitis from pancreatic adenocarcinoma using dual-phase computed tomography. J Comput Assist Tomogr 38:146–152. https://doi.org/10.1097/RCT.0b013e3182a9a431
Mulkeen AL, Yoo PS, Cha C (2006) Less common neoplasms of the pancreas. World J Gastroenterol 12:3180–3185
Hansen CP, Kristensen TS, Storkholm JH, Federspiel BH (2019) Solid pseudopapillary neoplasm of the pancreas: clinical-pathological features and management, a single-center experience. Rare Tumors. https://doi.org/10.1177/2036361319878513
Song T, Zhang QW, Duan SF et al (2021) MRI-based radiomics approach for differentiation of hypovascular non-functional pancreatic neuroendocrine tumors and solid pseudopapillary neoplasms of the pancreas. BMC Med Imag. https://doi.org/10.1186/s12880-021-00563-x
Law JK, Ahmed A, Singh VK et al (2014) A systematic review of solid-pseudopapillary neoplasms: are these rare lesions? Pancreas 43:331–337
Li X, Zhu H, Qian X et al (2020) MRI texture analysis for differentiating nonfunctional pancreatic neuroendocrine neoplasms from solid pseudopapillary neoplasms of the pancreas. Acad Radiol 27:815–823. https://doi.org/10.1016/j.acra.2019.07.012
Shi Y-J, Zhu H-T, Liu Y-L et al (2020) Radiomics analysis based on diffusion kurtosis imaging and T2 weighted imaging for differentiation of pancreatic neuroendocrine tumors from solid pseudopapillary tumors. Front Oncol 10:1624. https://doi.org/10.3389/fonc.2020.01624
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Research involving human participants and/or animals
This is a literature review without humans or animals data. Therefore, no ethical approval is required.
Informed consent
This is a literature review without humans or animals data. Therefore, no informed consent is required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Karmazanovsky, G., Gruzdev, I., Tikhonova, V. et al. Computed tomography-based radiomics approach in pancreatic tumors characterization. Radiol med 126, 1388–1395 (2021). https://doi.org/10.1007/s11547-021-01405-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-021-01405-0